Literature DB >> 19258071

Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model.

Cameron D Wright1, John C Kucharczuk, Sean M O'Brien, Joshua D Grab, Mark S Allen.   

Abstract

OBJECTIVE: To create a model for perioperative risk of esophagectomy for cancer using the Society of Thoracic Surgeons General Thoracic Database.
METHODS: The Society of Thoracic Surgeons General Thoracic Database was queried for all patients treated with esophagectomy for esophageal cancer between January 2002 and December 2007. A multivariable risk model for mortality and major morbidity was constructed.
RESULTS: There were 2315 esophagectomies performed by 73 participating centers. Hospital mortality was 63/2315 (2.7%). Major morbidity (defined as reoperation for bleeding [n = 12], anastomotic leak [n = 261], pneumonia [n = 188], reintubation [n = 227], ventilation beyond 48 hours [n = 71], or death [n = 63]) occurred in 553 patients (24%). Preoperative spirometry was obtained in 923/2315 (40%) of patients. A forced expiratory volume in 1 second < 60% of predicted was associated with major morbidity (P = .0044). Important predictors of major morbidity are: age 75 versus 55 (P = .005), black race (P = .08), congestive heart failure (P = .015), coronary artery disease (P = .017), peripheral vascular disease (P = .009), hypertension (P = .029), insulin-dependent diabetes (P = .009), American Society of Anesthesiology rating (P = .001), smoking status (P = .022), and steroid use (P = .026). A strong volume performance relationship was not observed for the composite measure of morbidity and mortality in this patient cohort.
CONCLUSIONS: Thoracic surgeons participating in the Society of Thoracic Surgeons General Thoracic Database perform esophagectomy with a low mortality. We identified important predictors of major morbidity and mortality after esophagectomy for esophageal cancer. Volume alone is an inadequate proxy for quality assessment after esophagectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19258071     DOI: 10.1016/j.jtcvs.2008.11.042

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  84 in total

1.  Outcomes after minimally invasive esophagectomy: review of over 1000 patients.

Authors:  James D Luketich; Arjun Pennathur; Omar Awais; Ryan M Levy; Samuel Keeley; Manisha Shende; Neil A Christie; Benny Weksler; Rodney J Landreneau; Ghulam Abbas; Matthew J Schuchert; Katie S Nason
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

2.  External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.

Authors:  J Matthew Reinersman; Mark S Allen; Claude Deschamps; Mark K Ferguson; Francis C Nichols; K Robert Shen; Dennis A Wigle; Stephen D Cassivi
Journal:  Eur J Cardiothorac Surg       Date:  2015-02-26       Impact factor: 4.191

3.  Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Authors:  Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Matthew G Hartwig; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

4.  Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.

Authors:  Paul J Speicher; Brian R Englum; Asvin M Ganapathi; Xiaofei Wang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

5.  Robotic assisted Ivor Lewis esophagectomy in the elderly patient.

Authors:  Andrea Abbott; Ravi Shridhar; Sarah Hoffe; Khaldoun Almhanna; Matt Doepker; Nadia Saeed; Kenneth Meredith
Journal:  J Gastrointest Oncol       Date:  2015-02

Review 6.  Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy.

Authors:  Edgard Engelman; Cécile Maeyens
Journal:  J Gastrointest Surg       Date:  2010-03-13       Impact factor: 3.452

7.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

8.  Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.

Authors:  Jeffrey Javidfar; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2015-11-11       Impact factor: 4.330

Review 9.  Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  Diabetes Care       Date:  2010-04       Impact factor: 19.112

10.  Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study.

Authors:  Shunsaku Takahashi; Norimasa Miura; Tomomi Harada; ZhongZhi Wang; Xinhui Wang; Hideyuki Tsubokura; Yoshiaki Oshima; Junichi Hasegawa; Yoshimi Inagaki; Goshi Shiota
Journal:  J Transl Med       Date:  2010-10-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.